Page 12 - Multidisciplinary Care News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multidisciplinary care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multidisciplinary Care Today - Breaking & Trending Today

Multidisciplinary Team Care Is Crucial for Successful Outcomes for Pregnant Patients on Dialysis, Says Dr Silvi Shah

Pregnancies for patients on dialysis are high risk and care by a multidisciplinary team is extremely important for a successful birth, explained Silvi Shah, MD, MS, FASN, assistant professor, Division of Nephrology and Hypertension, University of Cincinnati. ....

Silvi Shah , University Of Cincinnati , Division Of Nephrology , Multidisciplinary Care ,

Interpreting Results From RAMP 201: Avutometinib +/- Defactinib in Recurrent LGSOC

Expert oncologist David M. O’Malley, MD, reviews data from the RAMP 201 study utilizing avutometinib +/- defactinib in patients with recurrent low grade serous ovarian cancer and considers how this combination approach may impact the treatment landscape. ....

Expert Perspectives , Emerging Therapies , Low Grade Serous Ovarian Cancer , Ovarian Cancer , Ramp 201 , Novel Therapy , Combination Therapy , Recist Response , Efficacy Data , Efficacy Outcomes , Ramp 301 , Multidisciplinary Care , Healthcare Team , Clinical Trials , Clinical Trial Access , Access To Clinical Trials ,

Unmet Needs in the Treatment of HR+/HER2- Breast Cancer

Closing their discussion, the panel shares some remaining unmet needs in the treatment and management of patients with HR+/HER- breast cancer. ....

Optimizing Treatment , Multidisciplinary Approach , Breast Cancer , Hr Breast Cancer , Her2 Breast Cancer , Hr Her2 Breast Cancer , Her2 Negative Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatments , Breast Cancer Therapies , Multidisciplinary Care , Medical Oncologists , Radiation Oncologists ,

Considerations for Use of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer

Dr Naomi Dempsey explains how she decides on an appropriate CDK4/6 inhibitor for patients receiving first-line treatment for metastatic HR+/HER- breast cancer. ....

Naomi Dempsey , Optimizing Treatment , Multidisciplinary Approach , Breast Cancer , Hr Breast Cancer , Her2 Breast Cancer , Hr Her2 Breast Cancer , Her2 Negative Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatments , Breast Cancer Therapies , Multidisciplinary Care , Medical Oncologists , Radiation Oncologists ,

Common Toxicities of CDK4/6 Inhibitors in Patients With HR+/HER2- Metastatic Breast Cancer

The panel explains how treatment experience with CDK4/6 inhibitors varies for patients with HR+/HER- breast cancer, and which agents are best tolerated. ....

Optimizing Treatment , Multidisciplinary Approach , Patients With , Breast Cancer , Hr Breast Cancer , Her2 Breast Cancer , Hr Her2 Breast Cancer , Her2 Negative Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatments , Breast Cancer Therapies , Multidisciplinary Care , Medical Oncologists , Radiation Oncologists ,